Search Results 741-750 of 4536 for legumes
Study funds will cover some of the medical costs for participants of the eMERGE Genome Informed Risk Assessment study at Mayo Clinic or Mountain Park ...
The purpose of this study to look at certain blood proteins known as complement proteins in the whole blood of patients with systemic lupus erythematosus (SLE ...
Rajiv Gulati, M.D., Ph.D., conducts research at Mayo Clinic on cardiovascular diseases such as spontaneous coronary artery dissection (SCAD), ...
D., include the causes, pathophysiology, genetics and treatment of functional gastrointestinal disorders (FGIDs), particularly irritable bowel syndrome, ...
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products ...
About this study. As the global epidemic of obesity and diabetes mellitus spreads, an exponential rise in incident chronic kidney disease (CKD) complicated ...
This phase II trial studies how well olaparib works in treating patients with biliary tract cancer that has spread to other places in the body (metastatic) and ...
A Phase Ib/II, open label, multi-center, randomized study designed to assess the safety, tolerability, pharmacokinetics and preliminary anti-tumor activity of ...
National Human Genome Research Institute: Polygenic risk scores. CanRisk breast and ovarian cancer risk calculator. Publications. The eMERGE Network recommends ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.